FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20190507E00472
1. Date of relevant event: 02/05/2019
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 01801
4. Name of listed corporation: Innovent Biologics, Inc. - B 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,153,602,710
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) Yu
(Other names) De-Chao Michael
10. Name of director (Chinese):  
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
11031The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to take the underlying shares
 
 
2101Beneficial owner
 
6,901,796         
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position149,871,08712.99
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position156,772,88313.59
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position56,672,843
2201Interest of corporation controlled by you
Long position90,100,040
2307Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position10,000,000
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4105Unlisted derivatives - Physically settled
  HKD0    6,901,796
Long position
4105Unlisted derivatives - Physically settled
15/03/201915/03/2029HKD1.00HKD28.300  4,142,857
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
Great Biono Fortune LPP.O. Box 2075, #31 The Strand, 46 Canal Point Drive, Grand Cayman, KY1-1105, Cayman IslandsGreat Biono Fortune Limited0.00Y
Long position90,100,040
Great Biono Fortune LimitedP.O. Box 2075, #31 The Strand, 46 Canal Point Drive, Grand Cayman, KY1-1105, Cayman IslandsDe-Chao Michael Yu100.00N
Long position90,100,040
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
Yu Tong Family Irrevocable TrustAddresses of individuals are not displayed.
5103Founder of a discretionary trust who can influence how the trustee exercises his discretion
Long position10,000,000
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: In Box 24, the 6,901,796 shares represent the number of shares to be issued upon full vesting of the restricted shares granted to Yu De-Chao Michael under the Restricted Share Plan of the Company on 2 May 2019, the grant of which is subject to independent shareholders' approval at the extraordinary general meeting taking place on or around 14 June 2019.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 07/05/2019
(dd/mm/yyyy)